TFF completes dosing in Phase Ib clinical study for asthma drug November 15, 2021 Auto Bot Clinical Development 0 The firm is investigating viability of voriconazole inhalation powder, intended to treat and prevent invasive pulmonary aspergillosis in asthma patients.